Want to see JP:6368 full AI Analyst Report?

Organo Corp. (6368) Price & Analysis

1 Followers

6368 Stock Chart & Stats

¥15140.00

-¥140.00(-0.92%)

At close: Jul 27 4:00 PM EDT

¥15140.00

-¥140.00(-0.92%)

Day’s Range― - ―

52-Week Range¥8,810.00 - ¥20,145.00

Previous CloseN/A

Volume368.30K

Average Volume (3M)305.77K

Market Cap

¥694.76B

Enterprise Value¥825.74B

Total Cash (Recent Filing)¥31.05B

Total Debt (Recent Filing)¥34.40B

Price to Earnings (P/E)24.5

Beta1.69

Next Earnings

Aug 03, 2026

EPS Estimate

126

Next Dividend Ex-DateN/A

Dividend Yield1.32%

Share Statistics

EPS (TTM)617.72

Shares Outstanding46,359,700

10 Day Avg. Volume290,510

30 Day Avg. Volume305,770

Financial Highlights & Ratios

PEG Ratio1.25

Price to Book (P/B)4.38

Price to Sales (P/S)3.52

P/FCF Ratio21.30

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)677.61

Revenue Forecast (FY)¥202.48B

Bulls Say, Bears Say

Bulls Say

Consistent Revenue GrowthMulti-year revenue expansion demonstrates durable demand and scale benefits. Consistent top-line growth supports operating leverage, funds reinvestment, and reduces execution risk versus one-off spikes. Over a 2–6 month horizon this underpins predictable cash generation and strategic options.

Material Margin ExpansionSustained gross and net margin improvements indicate pricing power, better mix, and cost control that structurally enhance profitability. Higher margins convert incremental sales into stronger free cash flow, bolstering reinvestment capacity and resilience through business cycles.

Healthy Capital StructureModerate leverage with meaningful equity growth provides financial flexibility for capex, M&A, and downturns. A conservative capital structure reduces refinancing and solvency risk, helping sustain operations and investment priorities over the medium term despite tactical funding needs.

Bears Say

Rising DebtA material uptick in borrowings elevates leverage risk if cash generation slips. Higher debt increases fixed obligations and can constrain discretionary spending or strategic investments. Sustained earnings and FCF will be required to prevent balance-sheet stress over coming quarters.

Cash-Flow VolatilityHistoric swings in operating and free cash flow indicate working-capital and execution sensitivity. Intermittent negative cash years raise the risk that cyclical pressures or timing shifts could impair liquidity, making long-term investment and debt servicing less predictable.

Moderating Top-Line MomentumA slowdown in revenue growth suggests a maturing cycle or tougher comps, which can limit future operating-leverage gains. Without clear new products or market expansion, moderating growth may compress future margin and cash-flow expansion, challenging longer-term return assumptions.

Organo Corp. News

Organo Corporation Transfers Shares to Enhance Indonesian Water Treatment Venture

An announcement from Organo Corp. ( ($JP:6368) ) is now available. Organo Corporation announced its decision to transfer...

1y ago

6368

6368 FAQ

What was Organo Corp.’s price range in the past 12 months?

Organo Corp. lowest stock price was ¥8810.00 and its highest was ¥20145.00 in the past 12 months.

What is Organo Corp.’s market cap?

Organo Corp.’s market cap is ¥694.76B.

When is Organo Corp.’s upcoming earnings report date?

Organo Corp.’s upcoming earnings report date is Aug 03, 2026 which is in 7 days.

How were Organo Corp.’s earnings last quarter?

Organo Corp. released its earnings results on May 13, 2026. The company reported ¥226.23 earnings per share for the quarter, beating the consensus estimate of ¥189.28 by ¥36.95.

Is Organo Corp. overvalued?

According to Wall Street analysts Organo Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Organo Corp. pay dividends?

Organo Corp. pays a Semiannually dividend of ¥110 which represents an annual dividend yield of 1.32%. See more information on Organo Corp. dividends here

What is Organo Corp.’s EPS estimate?

Organo Corp.’s EPS estimate is 126.

How many shares outstanding does Organo Corp. have?

Organo Corp. has 46,359,700 shares outstanding.

What happened to Organo Corp.’s price movement after its last earnings report?

Organo Corp. reported an EPS of ¥226.23 in its last earnings report, beating expectations of ¥189.28. Following the earnings report the stock price went up 1.83%.

Which hedge fund is a major shareholder of Organo Corp.?

Currently, no hedge funds are holding shares in JP:6368

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Organo Corp.

Organo Corporation, a Tokyo-headquartered enterprise established in 1941 (and known as Japan Organo Co., Ltd. until its name change in 1966), is a global specialist in water treatment engineering. The company's business activities are structured into two main divisions: the Water Treatment Engineering Business Unit and the Performance Products Business Unit. It offers a comprehensive portfolio of water purification solutions, encompassing various pure water systems such as reverse osmosis (RO), regenerative (automatic and manual), electric regeneration, desktop, cabinet, electrode ionization high-purity, cartridge, and two-stage RO systems. Additionally, Organo supplies ultrapure water systems, available in desktop and cabinet models, alongside final polishing units. The company's equipment range extends to include alkaline electrolyzed water production machinery, homogenizers, electro conductivity and resistivity meters, and ion exchange filters. Beyond physical systems, Organo Corporation provides specialized chemicals for water, wastewater, and RO treatment. Its extensive selection of industrial filters covers micro, sanitary, polypropylene, and plastic housings, as well as micro, RO wound, PF cartridge, capsule, and PF carbon filters. Commercial water purifiers are also part of its product offering. Organo's expertise is applied across numerous industries: delivering ultrapure and multi-functional water production, wastewater treatment, valuable resource recovery, and organic solvent refining systems for the electronics sector; constructing water supply and sewage treatment facilities; supplying purified water, UF water, and water for injection production and supply systems, coupled with consulting services, for the pharmaceutical industry; providing critical solutions for power generation, including condensate filters, demineralizers, reactor and fuel pool cleanup, makeup water, and waste water treatment systems; and implementing sugar refining systems and associated equipment.